http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CL-2014001241-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ca1479897d6ff54f81178ad6c83f7944
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A01N43-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P33-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D495-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D491-048
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-519
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D487-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 2014-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_42ece551d2bb0b241ad6377d2d34ba42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c946e4ef9d1f4db11b9ba9afb098966b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_031d64aedbc0b039589fdf34c12c2522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ccd0f636ec53d66365f206e738126db9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1186b99924bf60b4b2f0a3a398f1837
publicationDate 2014-11-28-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CL-2014001241-A1
titleOfInvention Compounds derived from furanopyrimidines, thiophene pyrimidines or pyrrolpyrimidines, acetyl-coa carboxylase (acc) inhibitors; pharmaceutical composition; method to inhibit acc; method to treat disorders such as obesity, dyslipidemia, hyperlipidemia, cancer and fungal, parasitic or bacterial infections, among others.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11648245-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11464764-B2
priorityDate 2011-11-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8626599
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ54J08
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449242446
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID178510
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID411287437
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID21948582
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID833497
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP11029
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP85438
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP78820
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ00955
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID66988030
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID35761

Total number of triples: 43.